Promoting Innovation and Equity as Covid -19 Vaccines and Treatment Emerge

on
 
 
 
 
 
Health Affairs Today
The Latest Research, Commentary, and News from Health Affairs
Friday, August 14, 2020
Health Affairs Event: COVID-19 Vaccines & Treatment
As scientists and clinicians race to develop effective treatments to improve survival from COVID-19 and a vaccine to control the SARS-CoV-2 virus, Health Affairs has launched a new project to help identify for policy makers the critical decisions they will face that will have a substantial effect on whether and how quickly society reaps the benefits of these advances.

You are invited to join us on Monday, August 24, for a virtual symposium when some of the top minds in the field will join Health Affairs Editor-in-Chief Alan Weil for a discussion of these issues. Segments will focus on "Innovation" and "Equitable Access to Vaccines and Therapeutics."
Featuring:

  • Margaret A. Hamburg, Former Commissioner, US Food and Drug Administration
  • Orin Levine, Director, Global Delivery Programs, Bill & Melinda Gates Foundation
  • Rena M. Conti, Dean’s Research Scholar, Questrom School of Business, Boston University; Associate Professor, Markets, Public Policy, And Law; Associate Research Director, Institute For Health System Innovation And Policy
  • Mark Feinberg, President and CEO, IAVI
  • Garth Graham, Vice President and Chief Community Health Officer, CVS Health
  • Nicole Lurie, Strategic Adviser to the CEO, CEPI; Senior Lecturer, Harvard Medical School; and former Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services
  • Angela K. Shen, Visiting Research Scientist, Vaccine Education Center, Children’s Hospital of Philadelphia, and Captain (Ret.), US Public Health Services
  • Rebecca Lynn Weintraub, Assistant Professor of Medicine, Assistant Professor of Global Health and Social Medicine, Harvard Medical School
  • Gavin Mark Yamey, Professor, Practice of Global Health, Sanford School of Public Policy, Duke University
  • Others to be announced

Health Affairs is grateful to the following sponsors for their support of this work and this symposium:  Anthem, Inc., Amgen Inc., Avalere, Kaiser Permanente, Pharmaceutical Research and Manufacturers of America (PhRMA), Gilead Sciences, McKesson, Quest Diagnostics, Dynavax, Alexion, and Danaher.

Comments

Post a Comment